ISSN: 2332-0877
Journal of Infectious Diseases & Therapy
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
 
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business
 
Research Article
Open Access
 

Antimicrobial Sensitivity Pattern of Pseudomonas fluorescens after Biofield Treatment

Trivedi MK1, Patil S1, Shettigar H1, Gangwar M2 and Jana S2*
1Trivedi Global Inc., 10624 S Eastern Avenue Suite A-969, Henderson, NV 89052, USA
2Trivedi Science Research Laboratory Pvt. Ltd., Hall-A, Chinar Mega Mall, Chinar Fortune City, Hoshangabad Rd., Bhopal- 462026 Madhya Pradesh, India
Corresponding Author : Snehasis Jana
Trivedi Science Research Laboratory Pvt. Ltd.
Hall-A, Chinar Mega Mall, Chinar Fortune City
Hoshangabad Rd., Bhopal-462026 Madhya Pradesh, India
Tel: +91-755-6660006
E-mail: publication@trivedisrl.com
Received June 18, 2015; Accepted June 27, 2015; Published June 30, 2015
Citation: Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) Antimicrobial Sensitivity Pattern of Pseudomonas fluorescens after Biofield Treatment. J Infect Dis Ther 3:222. doi:10.4172/2332-0877.1000222
Copyright: © 2015 Trivedi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google
Visit for more related articles at Journal of Infectious Diseases & Therapy
 

Abstract

Global emergence of Pseudomonas fluorescens (P. fluorescens) displays a mechanism of resistance to all existing antimicrobials. Due to its strong ability to acquire resistance, there is a need of some alternative treatment strategy. Objective of this study was to investigate the effect of biofield treatment on antimicrobial sensitivity pattern of P. fluorescens. P. fluorescens cells were procured from MicroBioLogics in sealed packs bearing the American Type Culture Collection (ATCC 49838) number. Two sets of ATCC samples were taken in this experiment and denoted as A and B. ATCC-A sample was revived and divided into two groups (Gr) i.e. Gr.I (control) and Gr.II (revived); likewise, ATCC-B was labeled as Gr.III (lyophilized). Gr.II and III were given biofield treatment and were measured by MicroScan Walk-Away® system before and after treatment. Parameters studied in experiment were antimicrobial sensitivity, minimum inhibitory concentration (MIC), biochemical reactions, and biotype number of both control and treatment groups using MicroScan Walk-Away® system. Experimental results showed antimicrobials such as cefepime, cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, piperacillin, tetracycline, and tobramycin showed altered sensitivity and MIC values in treated group as compared to control. Biochemical reactions showed positive reaction in malonate, melibiose, nitrate, galactosidase, ornithine, raffinose, sorbitol, sucrose, tobramycin and Voges-Proskauer in Gr.II. Arabinose, colistin, glucose, and rhaminose also showed positive reactions in Gr.II on day 10 while arginine and cetrimide showed negative reaction in Gr.III as compared to control. Biochemical tests results revealed a change in biotype number in Gr.II (34101173, day 5), (77103177, a very rare biotype on day 10) and Gr.III (40000043) as compared to control (02041722). Organism was identified as Enterobacter cloacae (GrII, day 10) and Vibrio fluvialis (Gr.III, day 10) with respect to control. These findings suggest that biofield treatment made significant alteration in sensitivity pattern, MIC values, and biotype number of P. fluorescens.

Abstract
Global emergence of Pseudomonas fluorescens (P. fluorescens) displays a mechanism of resistance to all existing antimicrobials. Due to its strong ability to acquire resistance, there is a need of some alternative treatment strategy. Objective of this study was to investigate the effect of biofield treatment on antimicrobial sensitivity pattern of P. fluorescens. P. fluorescens cells were procured from MicroBioLogics in sealed packs bearing the American Type Culture Collection (ATCC 49838) number. Two sets of ATCC samples were taken in this experiment and denoted as A and B. ATCC-A sample was revived and divided into two groups (Gr) i.e. Gr.I (control) and Gr.II (revived); likewise, ATCC-B was labeled as Gr.III (lyophilized). Gr.II and III were given biofield treatment and were measured by MicroScan Walk-Away® system before and after treatment. Parameters studied in experiment were antimicrobial sensitivity, minimum inhibitory concentration (MIC), biochemical reactions, and biotype number of both control and treatment groups using MicroScan Walk-Away® system. Experimental results showed antimicrobials such as cefepime, cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, piperacillin, tetracycline, and tobramycin showed altered sensitivity and MIC values in treated group as compared to control. Biochemical reactions showed positive reaction in malonate, melibiose, nitrate, galactosidase, ornithine, raffinose, sorbitol, sucrose, tobramycin and Voges-Proskauer in Gr.II. Arabinose, colistin, glucose, and rhaminose also showed positive reactions in Gr.II on day 10 while arginine and cetrimide showed negative reaction in Gr.III as compared to control. Biochemical tests results revealed a change in biotype number in Gr.II (34101173, day 5), (77103177, a very rare biotype on day 10) and Gr.III (40000043) as compared to control (02041722). Organism was identified as Enterobacter cloacae (GrII, day 10) and Vibrio fluvialis (Gr.III, day 10) with respect to control. These findings suggest that biofield treatment made significant alteration in sensitivity pattern, MIC values, and biotype number of P. fluorescens.
Keywords
Pseudomonas fluorescens; Antibiotic susceptibility; Biofield treatment; Biochemical reactions; Biotyping Introduction
Pseudomonas fluorescens (P. fluorescens) is Gram negative, obligate aerobic, and considered as a psychrotrophic microorganism, unable to grow at temperatures above 32°C. Fluorescent species of pseudomonas, initially considered to be nonpathogenic for human. Since 1953, human pathogenicity has been reported, when Pittman describes its presence and characteristics in blood and caused severe to fatal symptoms in infected patients [1]. P. fluorescens is an opportunistic pathogen, and able to inhabit in many environment like plants, soil, and water surfaces. Different clinical strains of P. fluorescens have been reported for high hemolytic activity, which induce cyctotoxic and proinflammatory responses in epithelial intestinal cells [2]. P. fluorescens also resides in the plant’s rhizosphere and produces a variety of secondary metabolites including antibiotics against soil borne plant pathogens, but potential risk with P. fluorescens causing nosocomial infections even higher incidence rate than P. aeruginosa [3]. Some of these strains found in human digestive tract with low commensal level while some found in refrigerated food products with its psychrotrophic characters [4]. Recently, a specific antigen of was detected in serum of ileal Crohn's disease patient [5]. P. fluorescens responsible for causing various human diseases and considered as a pathogenic microorganism. Different antimicrobial combination therapies are preferred by microbiologist to alter its sensitivity but due to their associated side effects, alternate approaches are adopted by healthcare professionals. Among various alternate and complementary therapies, biofield might be a new approach to do such alterations. Biofield is the name given to the electromagnetic field that permeates and surrounds living organisms. It is the scientifically preferred term for the biologically produced electromagnetic and subtle energy field that provides regulatory and communication functions within the organism. In spite of countless study reports of the effectiveness of biofield therapies [6], there are very few well controlled and peer-reviewed experimental studies [7]. According to law of mass-energy inter-conversion [8], the conversion of mass into energy is well stabilized, but its inversion i.e. energy into mass is not yet proved scientifically. Whenever these electrical signals fluctuate with time, the magnetic field generates as per the Ampere-Maxwell law, and cumulatively known as electromagnetic field. As responses by humans can be accounted for by the placebo effect, these experiments on lower organisms are designed in order to directly test the impact of biofield energy through scientific studies to rule out the placebo effect. It is widely accepted that lyophilization is the most preferred method to store and transport microbial cultures. Therefore, changes in the biochemical and enzymatic characteristics of an organism cannot be possible at this storage condition. Mr. Mahendra Trivedi’s biofield treatment has been studied significantly and its effects are considerably altered the antibiotic susceptibility and biochemical reactions of microbes against tested antimicrobials [9-11]. However, researchers found significant inhibitory effect of biofield in different cancer cell models [12-14]. It has also shown significantly altered the crystalline and powder characteristics of metals [15,16]. In agriculture, biofield treated crops have been reported for a significant change on growth, characteristics and yield of plants [17-19]. There are scanty reports on investigating biofield therapies against microbes. In the present study, impact of biofield treatment on P. fluorescens was evaluated and its antimicrobial susceptibility pattern, MIC value, biochemical reactions, and biotype were studied in revived and lyophilized cells of P. fluorescens as compared to control. Material and methods
P. fluorescens ATCC 49838 (American Type Culture Collection) strains were procured from MicroBioLogics, Inc., USA, in two sets A and B. The antimicrobials and biochemical used in the study were procured from Sigma-Aldrich. Two different sealed packs were stored with proper storage conditions until further use. The antimicrobial susceptibility, biochemical reactions and biotype number were estimated with the help of Microscan Walk-Away system® (Dade Behring Siemens) using NBPC30 panel with respect to control groups. Study Design Two ATCC samples (ATCC A and B) of P. fluorescens were grouped and subjected to biofield treatment. ATCC A sample was revived and divided into two groups (Gr) viz. Gr.I (control) and Gr.II (revived); likewise, ATCC B was labeled as Gr.III (lyophilized). Then group II and III were treated with Mr. Trivedi’s biofield energy. Gr.II was assessed on the 5th and 10th days after treatment while Gr.III was assessed on 10th day only. Finally, all the groups (control and treated) were investigated for antimicrobial susceptibility, biochemical reactions pattern and biotyping.

Antimicrobial susceptibility assay Antimicrobial susceptibility pattern of P. fluorescens was studied using MicroScan Walk-Away® using NBPC30 panel as per manufacturer's instructions. The qualitative antimicrobial susceptibility pattern (S: Susceptible, I: Intermediate, and R: Resistant) and minimum inhibitory concentration (MIC) were determined by observing the change in antimicrobial concentration as per Clinical and Laboratory Standards Institute (CLSI) guidelines [20].

Biochemical reaction and biotype number studies The biochemical reactions and biotype number followed by organism identification after biofield treatment of P. fluorescens were studied using MicroScan Walk-Away® system [21]. Alteration in biochemical reactions patterns after biofield treatment were analyzed using following 33 biochemical such as acetamide, adonitol, arabinose, arginine, cetrimide, cephalothin, citrate, colistin, esculin, hydrolysis, nitrofurantoin, glucose, hydrogen sulfide, indole, inositol, kanamycin, lysine, malonate, melibiose, nitrate, oxidation-fermentation, galactosidase, ornithine, oxidase, penicillin, raffinose, rhaminose, sorbitol, sucrose, tartarate, tryptophan deaminase, tobramycin, urea, and Voges-Proskauer.

Results
Antimicrobial susceptibility assay The data pertaining to the antimicrobial susceptibility tests and details of MIC values were observed and reported in Table 1 and 2 respectively. The result of biofield treatment showed that sensitivity pattern of ceftriaxone and tetracycline converted from I → R Gr.II on day 5 and 10. Ceftazidime, ciprofloxacin and piperacillin, converted from S → R in Gr.II on day 5 and 10 with changes in MIC values as compared to control. Cefotaxime sensitivity pattern changed from I → R in Gr.II while in cefepime, changed from I → R only at day 10 in Gr.II. Tobramycin sensitivity pattern after treatment converted from S → I with altered MIC value on day 5 while S → R on day 10 in Gr.II. In case of norfloxacin, change in MIC value was reported greater than 8 µg/mL in Gr.II as compared with control. Rest of tested antimicrobials did not showed any change in susceptibility pattern and MIC values after biofield treatment as compared to control (Table 2).

Biochemical study Biochemical tests denoted with codes are summarized in Table 3. Results showed positive reactions (i.e. (-) negative to (+) positive) in case of malonate, melibiose, nitrate, galactosidase, ornithine, raffinose, sorbitol, sucrose, tobramycin, and Voges-Proskauer on day 5 and 10 in Gr II on both days with respect to control. Arabinose, colistin, and rhaminose showed negative reactions (i.e. (+) positive to (-) negative) in Gr II only on day 10 as compared to control. Arginine was converted into positive to negative reaction in Gr.III and in Gr.II at day 5 only. Cetrimide showed negative reaction in Gr.III as compared to control. Glucose showed positive reaction at day 10 in Gr.II and Gr.III as compared to control.

Study of Biotype number Biochemical tests result revealed a change in biotype number in Gr.II on day 5 (34101173) and day 10 (77103177, a very rare biotype) as compared to control (02041722). In Lyophilized treated group showed a change, not only in biotype number (40000043), but also changed to new species. Organism identified as Vibrio fluvialis (Gr.III, day 10) and Enterobacter cloacae (GrII, day 10) with respect to control (Table 4).

Discussion
Due to the high frequency of antimicrobial resistance among clinical isolates of P. fluorescens, it causes serious problems in the choice of an appropriate antimicrobials in the past 15 years. P. fluorescens was isolated in bottled water and causing bacteremia and pseudo bacteremia in immunocompromised patients in hospitals from contamination of disinfectants and blood collecting tubes [22]. Although P. fluorescens considered to be non-pathogenic to humans, but recent reports on clinical strains of P. fluorescens have cause serious health problems [23-25] which require some alternative treatment approach. Ceftazidime is the choice of drug used against P. fluorescens infection, either alone or in combination with gentamicin. P. fluorescens was highly sensitive to kanamycin, tetracycline, and chloramphenicol at very low concentration [26]. This study results showed that biofield treatment has an alteration in sensitivity pattern of selected antimicrobials mentioned in Table 1 with respect to control. Ceftriaxone, tetracycline, ceftazidime, ciprofloxacin, piperacillin, cefotaxime, and tobramycin showed an alteration in sensitivity pattern and MIC values after biofield treatment with respect to control (Tables 1 and 2). Based on literatures, important biochemical characteristics test of Pseudomonas species gives negative reaction in case of Voges-Proskauer, indole, and methyl red, while positive reaction in catalase test. While some species i.e. P. fluorescens show a positive oxidase test [27]. In this experiment, results of biochemical reactions showed positive reaction in arginine, cetrimide while negative reaction in Voges-Proskauer, arabinose, colistin, rhaminose, malonate, melibiose, nitrate, galactosidase, ornithine, raffinose, sorbitol, sucrose, and tobramycin. After biofield treatment, results showed altered biochemical reactions which suggest that biofield treatment might cause some changes at enzymatic or metabolic pathway leading to significant phenotypic alteration in P. fluorescens. Biotyping makes use of the pattern of metabolic activities expressed by an isolate, colonial morphology and environmental tolerances. In this experiment, biotyping was performed using automated system and found a significant changed in the biotype number and identified a new species in treated groups, and organism identified as Enterobacter cloacae (Gr.II, day 10) and Vibrio fluvialis (Gr.III, day 10) with respect to control, P. fluorescens. Hence, results support that biofield treatment has altered the biotype number and shown a significant change of organism but additional molecular methods are further required to study these changes. In biomedical health care system, biofield therapies are very popular and claims to enhance human well-being and other metabolic pathways [28-30]. In microbiology, biofield treatment altered the phenotypic characteristics of microorganism, results supposed the involvement of electromagnetic field that acts on molecular level at cell receptor protein. Biofield alteration, modifies ligand-receptor interaction which causes alteration in phenotypic characters. Research reports suggest that extremely low frequency electromagnetic fields (ELF-EMF) could alter transmembrane Ca2+ concentration which causes damage and developmental defects in different organs [31,32]. ELF-EMF also induce phosphorylation of receptor protein in T-cell membrane [33]. Hence, it is assumed that biofield treatment made some alteration at enzymatic or genetic level which manifested in phenotypic alteration. Experimental data showed that, biofield treatment induces changes in susceptibility pattern of antimicrobials, biochemical reactions, MIC values, and biotype number. Biofield treatment is cost effective and has been experimentally demonstrated an alternative approach to study the alteration in sensitivity pattern of microorganism. Conclusion
Study results conclude that biofield treatment has altered the susceptibility pattern and MIC value of P. fluorescens. Biochemical study revealed a significant changes in most of the biochemical reactions after biofield treatment. Biotype study showed a significant change in number and species of microorganism after biofield treatment as compared to control. Acknowledgement
Authors gratefully acknowledged the whole team of PD Hinduja National Hospital and MRC, Mumbai, Microbiology Lab for their support. Conflict of Interest
The authors declare that they have no competing interests.
References

































References


































Tables at a glance

image   image   image   image
Table 1   Table 2   Table 3   Table 4
Select your language of interest to view the total content in your interested language
 
Share This Article
   
 
   
 
Relevant Topics
Disc Adaptive Immunity
Disc Advanced Therapies
Disc Allergy Immunology
Disc Anatomical Pathology
Disc Anthrax
Disc Automated Tissue Image Analysis
Disc Bacteraemia
Disc Bacteria Induced Neuropathies
Disc Bacterial Ecology
Disc Bacterial Genomics
Disc Bacterial Infections
Disc Bacterial Toxin
Disc Bacteriology
Disc Brain Infection
Disc Cellular Immunology
Disc Cellular Pathology
Disc Chemical Pathology
Disc Chicken Pox
Disc Clinical Immunology
Disc Clinical Pathology
Disc Colon Infection
Disc Conjunctivitis
Disc Cooperative Human Tissue Network
Disc Diagnostic Immunology
Disc Escherichia coli
Disc Evolutionary Immunology
Disc Experimental Pathology
Disc Fungal Infection
Disc HIV and AIDS Research
Disc Hematopathology
Disc Herpes Virus
Disc Host-Pathogen Interactions
Disc Human Papilloma Virus
Disc Infection
Disc Infection in Blood
Disc Infections Prevention
Disc Infectious Disease in Children
Disc Infectious Diseases in Children
Disc Inflammatory Disorders
Disc Influenza
Disc Intestinal Parasites
Disc Leprosy
Disc Listeriosis
Disc Lyme Disease
Disc Neuro-HIV and Bacterial Infection
Disc Neuro-Infections Induced Autoimmune Disorders
Disc Neurocystercercosis
Disc Neurocysticercosis
Disc Neuroepidemiology
Disc Neuroinfectious Agents
Disc Neuroinflammatory Disorders
Disc Neuropathology
Disc Neurosyphilis
Disc Neurovirology
Disc Ocular Immunology and inflammation
Disc Parasitic Infection
Disc Parasitic Worms
Disc Parasitology
Disc Phytopathology
Disc Rare Infectious Disease
Disc Renal Pathology
Disc Respiratory Tract Infections
Disc Rickettsioses
Disc Salmonella
Disc Salmonellosis
Disc T Cell Lymphomatic Virus
Disc Toxoplasmosis
Disc Translational Immunology
Disc Transplantation Immunology
Disc Treatment for Infectious Diseases
Disc Tumor Immunology
Disc Vaccine Immunology
Disc Viral Encephalitis
Disc Viral Immunology
Disc Viral Infection
Disc Yeast Infection
Disc Zoonotic Bacterial Diseases
 
Recommended Journals
Disc Clinical Infectious Disease Journal
Disc Immunology Journal
Disc Pathology Journal
Disc Bacteriology Journal
Disc Neuroinfectious Disease Journal
  View More»
 
Recommended Conferences
Disc 5th International Conference and Exhibition on Occupational Health & Safety
June 09-10, 2016, Dallas, USA
Disc 4th International Conference on Epidemiology and Public Health  
October 03-05, 2016 London, United Kingdom
Disc 7th World Congress and Expo on Applied Microbiology
November 10-12, 2016 Istanbul, Turkey
Disc 7th World Congress on Virology
November 21-23, 2016 Baltimore, USA
Disc 10th International Conference on Nursing and Healthcare
December 05-07, 2016 Dallas, USA
View More»
 
Article Tools
Disc Export citation
Disc Share/Blog this article
 
Article usage
  Total views: 11582
  [From(publication date):
June-2015 - May 29, 2016]
  Breakdown by view type
  HTML page views : 7852
  PDF downloads :3730
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version